Search Results 271-280 of 17551 for Cytology

  1. Mayo Clinic research uses artificial intelligence to develop inexpensive, widely available early detector of silent heart disease

    ... cytology for cervical cancer. In addition, in patients without ventricular dysfunction, those with a positive AI screen were at four times the risk of ...

  2. Thyroid Autoimmunity Biobank - Clinical Trials

    US pattern or cytology or pathology consistent with HT. Graves' Orbitopathy. ≥18 years of age; Presence of manifestations for GO, both inactive and active ...

  3. Low-grade UTUC Treated with Nadofaragene Firadenovec Administered to Renal Pelvis - Mayo Clinic

    UTUC characterised by one or more of the following: * High-grade cytology or high-grade histology * Multi-focal UTUC * Exception: Subjects with low-grade ...

  4. A Safety Study of SEA-TGT (SGN-TGT) in Patients With Advanced Cancer - Mayo Clinic

    - NSCLC: histological or cytological confirmed metastatic disease. Participants must have received no prior anti-PD-1/PD-L1 therapy allowed. - HNSCC ...

  5. Loncastuximab Tesirine in WM - Mayo Clinic

    shortness of breath) unless proven by cytology to be malignant due to WM. - Pregnant or breastfeeding. - Participants with known CNS lymphoma ...

  6. A Study of Application of Clonal Analysis to Study Flow Sorted Clinical Samples from Patients with Advanced Solid Tumors - Mayo Clinic

    Suspected or cytological/histologically confirmed advanced solid tumors undergoing standard of care image guided biopsy or surgical procedure; Age > 18 years ...

  7. A Study to Assess the Effectiveness and Safety of UGN-102 as a Primary Chemoablation Agent in Patients with Low Grade Non-Muscle-Invasive Bladder Cancer (LG NMIBC) at Intermediate Risk of Recurrence - Mayo Clinic

    Has negative voiding cytology for HG disease at or within 6 weeks of enrollment. Willing to use 2 acceptable forms of effective contraception from ...

  8. Vorinostat, Temozolomide, or Bevacizumab in Combination with Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients with Newly Diagnosed High-Grade Glioma - Mayo Clinic

    No positive CSF cytology. ECOG performance status (PS) 0-2. Karnofsky PS 50-100% (patients > 16 years of age); Lansky PS 50-100% (patients ≤ 16 years of age).

  9. Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma - Mayo Clinic

    CSF cytology by lumbar puncture must be done if clinically indicated and determined to be safe prior to study enrollment. If cytology proves positive, the ...

  10. Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL - Mayo Clinic

    Pleural effusion with positive cytology for lymphoma; Patients known to be HIV positive, hepatitis B positive, or hepatitis C positive; Known autoimmune ...